Table 2.
Outcomes (N) | AWMD (95% CI) | ROB | Inconsistency | Indirectness | Imprecision | Other considerations | Sample size | Evidence quality | |
---|---|---|---|---|---|---|---|---|---|
Interventions | Comparison | ||||||||
HbA1c (3) | -0.283 (-0.561, -0.004) | none | none | none | serious | none | 203 | 208 | MODERATE ⊕⊕⊕○ |
FBG (3) | -0.314 (-1.599, 0.972) | none | serious | none | serious | none | 203 | 208 | MODERATE ⊕⊕⊕○ |
2h-PG (3) | -0.152 (-0.778, -0.474) | none | serious | none | serious | none | 203 | 208 | MODERATE ⊕⊕⊕○ |
AWMD, adjusted weighted mean difference; ROB, risk of bias; N, numbers of RCTs; GRADE, Grading of Recommendations Assessment, Development and Evaluation